State of Alaska Department of Revenue’s Sarepta Therapeutics SRPT Stock Holding History

State of Alaska Department of Revenue’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$624K	Sell	34,768 -17,238	-33%	-$326K	0.01%	1310
2026 Q1	$1.13M	Sell	52,006 -1,274	-2%	-$24.7K	0.01%	1015
2025 Q4	$1.15M	Buy	53,280 +4,167	+8%	+$87.8K	0.01%	1000
2025 Q3	$946K	Buy	49,113 +38,043	+344%	+$678K	0.01%	1107
2025 Q2	$189K	Sell	11,070 -105	-0.9%	-$4.48K	﹤0.01%	1564
2025 Q1	$713K	Buy	11,175 +285	+3%	+$30K	0.01%	1194
2024 Q4	$1.32M	Sell	10,890 -145	-1%	-$17.8K	0.01%	911
2024 Q3	$1.38M	Buy	11,035 +750	+7%	+$104K	0.01%	898
2024 Q2	$1.63M	Buy	+10,285	New	+$1.32M	0.02%	754
2019 Q3	–	Sell	-7,767	Closed	-$1.18M	–	1732
2019 Q2	$1.18M	Buy	7,767 +25	+0.3%	+$3.04K	0.02%	681
2019 Q1	$922K	Sell	7,742 -445	-5%	-$57.2K	0.02%	758
2018 Q4	$893K	Buy	8,187 +501	+7%	+$62.7K	0.02%	690
2018 Q3	$1.24M	Buy	7,686 +166	+2%	+$22.7K	0.02%	654
2018 Q2	$993K	Buy	+7,520	New	+$709K	0.02%	708

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State of Alaska Department of Revenue's SRPT Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Sarepta Therapeutics (SRPT) stake by 33% in Q2 2026, selling an estimated $326K and leaving 34,768 shares worth $624K. The position accounts for 0.01% of the portfolio, ranked #1310.

State of Alaska Department of Revenue first reported a position in SRPT in Q2 2018 and has held it in 14 quarters since. The position peaked at $1.63M in Q2 2024. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

State of Alaska Department of Revenue held 34,768 shares of Sarepta Therapeutics worth $624K as of Q2 2026.
State of Alaska Department of Revenue sold 17,238 Sarepta Therapeutics shares in Q2 2026, an estimated $326K.
Sarepta Therapeutics made up 0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #1310 holding.
State of Alaska Department of Revenue first reported a position in Sarepta Therapeutics in Q2 2018 and has held it in 14 quarters since.
State of Alaska Department of Revenue's Sarepta Therapeutics position peaked at $1.63M in Q2 2024.
323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.